Elimination of graft-versus-host disease by in-vitro depletion of alloreactive lymphocytes with a monoclonal rat anti-human lymphocyte antibody (CAMPATH-1).

類似資料

• Elimination of graft versus host disease in matched allogeneic leukemic transplant recipients using CAMPATH-1.
  著者:: Slavin, S, 等
  出版事項: (1985)
• ALLOGENEIC BONE-MARROW TRANSPLANTATION FOR LEUKEMIA USING CAMPATH-1 MONOCLONAL-ANTIBODIES AND POSTTRANSPLANT ALLOIMMUNIZATION WITH DONOR LYMPHOCYTES
  著者:: Naparstek, E, 等
  出版事項: (1993)
• Allogeneic bone marrow transplantation without graft-v-host disease: true tolerance of graft against the host through depletion of donor T lymphocytes pregrafting in malignant and nonmalignant disorders.
  著者:: Slavin, S, 等
  出版事項: (1987)
• Prevention of immune-mediated corneal graft destruction with the anti-lymphocyte monoclonal antibody, CAMPATH-1H.
  著者:: Newman, D, 等
  出版事項: (1995)
• Engraftment of marrow allografts treated with Campath-1 monoclonal antibodies.
  著者:: Naparstek, E, 等
  出版事項: (1999)